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Research
Air pollution exposure is an established 
risk factor for cardiovascular morbidity and 
mortality (Brook et al. 2010), especially 
exposure derived from traffic and industrial 
sources (Laden et al. 2000; Lall et al. 2011; 
Lipfert et al. 2006; Pope et al. 2002; Sarnat 
et al. 2008). Acute exposure to combustion-
derived particulate matter (PM) is associated 
with the onset of myocardial infarction 
and admissions to hospital in survivors of 
myocardial infarction and has been proposed 
as a trigger for acute cardiovascular events 
(Peters et al. 2004; von Klot et al. 2005). 
Although estimates vary, chronic exposure to 
air pollution has been estimated to increase 
all-cause mortality by 2–4% per 10-μg/m3 
increase in PM (Dockery et al. 1993; Pope 
et al. 2002), with most deaths due to cardio-
vascular disease (Miller et al. 2007). The 
World Health Organization estimates that 
outdoor urban air pollution results in around 
800,000 deaths worldwide each year (United 
Nations Environment Programme 2006).
In controlled exposure studies, inhalation 
of PM air pollution affects blood pressure 
and causes abnormalities in vascular func-
tion, coagulation, and myocardial perfusion 
(Mills et al. 2009). These responses provide a 
plausible mechanism to explain the observed 
increase in acute cardiovascular events and 
cardiovascular mortality after exposure to PM 
air pollution. However, although acute expo-
sure induces these adverse effects, whether 
improvements in cardiovascular health can be 
achieved by interventions targeted to reduce 
exposure in those living and working in highly 
polluted urban environments is unclear.
Major environmental health policy inter-
ventions can have a substantial impact on 
the health of populations, as evidenced by 
major reductions in cardiovascular events after 
the banning of bituminous coal in Dublin, 
Ireland, in 1990 (Clancy et al. 2002) and, 
more recently, with the restriction of smoking 
in public places (Pell et al. 2008). However, 
such environmental interventions may be 
difficult to implement in rapidly developing 
countries where economic growth is depen-
dent on road traffic and heavy industry (Smith 
et al. 2009). More practical solutions to reduce 
individual exposure and protect susceptible 
persons are urgently required. Therefore, we 
investigated the effects of a simple face mask 
intervention to reduce PM air pollution expo-
sure on measures of cardiovascular health in 
patients with coronary heart disease.
Methods
Subjects. One hundred and two patients were 
recruited from the Fuwai Hospital, Beijing, 
China, in March 2009. All patients were 
nonsmokers and had a history of coronary 
heart disease. Exclusion criteria were a history 
of arrhythmia, severe coronary artery disease 
without revascularization, resting conduction 
abnormality, digoxin therapy, uncontrolled 
hypertension, renal or hepatic failure, or an 
acute coronary syndrome within the previous 
3 months. Patients’ medical histories were 
recorded from the case notes, and baseline 
anthropometric and biochemical measures 
were performed on recruitment. All subjects 
gave their written informed consent, and the 
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Background: Air pollution exposure increases cardiovascular morbidity and mortality and is a 
major global public health concern.
oBjectives: We investigated the benefits of reducing personal exposure to urban air pollution in 
patients with coronary heart disease.
Methods: In an open randomized crossover trial, 98 patients with coronary heart disease walked 
on a predefined route in central Beijing, China, under different conditions: once while using a 
highly efficient face mask, and once while not using the mask. Symptoms, exercise, personal air 
pollution exposure, blood pressure, heart rate, and 12-lead electrocardiography were monitored 
throughout the 24-hr study period.
results: Ambient air pollutants were dominated by fine and ultrafine particulate matter (PM) 
that was present at high levels [74 μg/m3 for PM2.5 (PM with aerodynamic diamater <2.5 μm)]. 
Consistent with traffic-derived sources, this PM contained organic carbon and polycyclic aromatic 
hydrocarbons and was highly oxidizing, generating large amounts of free radicals. The face mask 
was well tolerated, and its use was associated with decreased self-reported symptoms and reduced 
maximal ST segment depression (–142 vs. –156 μV, p = 0.046) over the 24-hr period. When 
the face mask was used during the prescribed walk, mean arterial pressure was lower (93 ± 10 
vs. 96 ± 10 mmHg, p = 0.025) and heart rate variability increased (high-frequency power: 54 vs. 
40 msec2, p = 0.005; high-frequency normalized power: 23.5 vs. 20.5 msec, p = 0.001; root mean 
square successive differences: 16.7 vs. 14.8 msec, p = 0.007). However, mask use did not appear to 
influence heart rate or energy expenditure.
conclusions: Reducing personal exposure to air pollution using a highly efficient face mask 
appeared to reduce symptoms and improve a range of cardiovascular health measures in patients with 
coronary heart disease. Such interventions to reduce personal exposure to PM air pollution have the 
potential to reduce the incidence of cardiovascular events in this highly susceptible population.
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study was reviewed and approved by the local 
research ethics committee.
Study design. Subjects attended the Fuwai 
Hospital or the ChaoYang Hospital in Beijing 
on two occasions, with at least a week between 
visits (median time between visits was 9 days), 
between March and May 2009. Each subject 
attended the same hospital on each visit. In a 
prospective randomized open blinded end point 
(PROBE) crossover study, subjects walked for 
2 hr between 0900 hours and 1100 hours along 
prescribed city center routes [see Supplemental 
Material, Figure S1 (http://dx.doi.org/10.1289/
ehp.1103898)] in Beijing, using a highly effi-
cient face mask on one study visit but not the 
other (Dust Respirator 8812; 3M, St. Paul, 
MN, USA). This mask consists of a light-
weight polypropylene filter, which is effective at 
removing airborne PM without affecting ambi-
ent gases. The mask has an expiration valve, 
complies with EN149:2001 FFP1 European 
Standard (British Standards Institute 2001), 
and has an assigned protection factor of 4 [i.e., 
it can be worn in atmospheres containing up to 
four times the workplace exposure limit (WEL) 
as defined by the U.K. Health and Safety 
Executive (2011). [The WEL for respirable car-
bon particles (carbon black), is 3.5 mg/m3 over 
an 8-hr time weighted average.] Mask use was 
randomly assigned to the first or second visit 
using balanced computer-generated random-
ization. In order to maximize the difference in 
PM air pollution exposure, subjects wore the 
mask for 24 hr before the mask study day, in 
addition to wearing it during the 24 hr study 
day, and were given instructions to wear the 
mask at all times while outdoors and as much as 
possible when indoors. Subjects’ activities after 
the prescribed walk were not restricted, and 
they were instructed to continue their  normal 
daily routines.
Personal pollution exposure and activity 
monitoring. Personal air pollutant exposure 
was determined using monitoring equipment 
contained within a backpack. Fine particulate 
matter (PM2.5; PM with aerodynamic diameter 
≤ 2.5 μm) was determined using a DataRAM 
monitor (model pDR-1500; Thermo Scientific, 
Franklin, MA, USA), and particle number was 
measured using a condensation particle coun-
ter (model CPC 3007; TSI Instruments Ltd., 
High Wycombe, UK). Ambient temperature 
and relative humidity were recorded using an 
external sensor (Omegaette® model HH-314; 
Omega Engineering Ltd., Stamford, CT, 
USA). Gaseous pollutants were measured using 
a multigas analyzer with electrochemical sen-
sors for carbon monoxide, sulfur dioxide, and 
nitrogen dioxide (model X-am 7000; Dräger 
Safety, Lübeck, Germany). During the pre-
scribed walk, physical activity was measured 
using global positioning system (GPS) track-
ing (eTrex Summit HC GPS unit; Garmin, 
Olathe, KS, USA), and energy expenditure was 
estimated using activity data and anthropomet-
ric data as described previously (Langrish et al. 
2009). The estimated PM exposure when wear-
ing the mask was determined based on mea-
surements of mask filter efficacy as described 
previously (Langrish et al. 2009).
Background pollution monitoring. 
Background exposure was recorded from 
permanent monitoring stations in the district 
where the patients walked on the study day 
(Beijing Municipal Environmental Protection 
Bureau 2009). Airborne PM was collected 
onto Teflon filters (Pall Corp., Ann Arbor, 
MI, USA) in three size fractions: coarse 
(mean aerodynamic diameter, 2.5–10 μm), 
fine (0.18–2.5 μm), and ultrafine (< 0.18 μm) 
using a MOUDI cascade impactor (MSP 
Corp., Shoreview, MN, USA).
PM mass was determined gravi metrically 
for each size fraction from the above filters 
after temperature and humidity conditioning 
and subsequently analyzed for elemental and 
organic carbon fractions, metals and cations, 
nitrate and sulfate anions, and organic matter.
Chemical and toxicological analysis of 
collected PM. Collected PM samples were 
analyzed for total carbon content, as well 
as elemental and organic carbon fractions, 
using the Sunset method (National Institute 
for Occupational Safety and Health 2003). 
Metals and cations were determined using 
inductively coupled plasma mass spectrometry 
(ICP-MS) after pretreatment with nitric acid. 
Nitrate and sulfate anions were determined 
after extraction with water using liquid chro-
matography paired with ICP-MS. Organic 
matter was extracted from filters by ultrasoni-
fication with toluene and analyzed using gas 
 chromatography/mass spectrometry.
The oxidative potential of PM was assessed 
using electron paramagnetic resonance (EPR) 
(Miller et al. 2009). EPR was used to estab-
lish oxygen-centered free radical generation 
from the collected PM in the absence of tis-
sue. Filters for all size fractions were pooled 
and sonicated in phosphate-buffered saline to 
give a final concentration of 1 mg particles/mL. 
Solutions were incubated with the spin-trap 
1-hydroxyl-2,2,6,6,-tetra methyl-4-oxo-
piperidine (Tempone-H; 1 mM) (Enzo Life 
Sciences, Exeter, UK), loaded into a capillary 
tube and assessed at 37°C in an X-band EPR 
spectrometer (model MS-200; Magnettech, 
Berlin, Germany) as described previously (Miller 
et al. 2009). Pyrogallol (100 μM) was used as a 
positive control, and samples were compared 
with the National Institute of Standards and 
Technology (NIST; Gaithersburg, MD, USA) 
standard reference materials for urban dust 
(SRM-1649a; 1 mg/mL) and diesel exhaust 
PM (SRM-2975; 10 μg/mL).
Electrocardiography and blood pressure 
monitoring. Continuous 12-lead electro-
cardiography (ECG) was assessed with a 
digital Holter recorder (Lifecard 12; Spacelabs 
Healthcare Ltd., Hertford, UK) using the 
Pathfinder automated arrhythmia analysis 
package (version 8.701, DelMar Reynolds’ 
Pathfinder Digital; Spacelabs Healthcare 
Ltd.). Identified arrhythmias were individually 
inspected and verified or deleted as appro-
priate, and heart rate variability was assessed 
using the DelMar Reynolds’ HRV Tools soft-
ware package as described previously (Langrish 
et al. 2009). ST segment analysis was per-
formed at the J-point +80 msec in three rep-
resentative leads (II, V2, and V5) that were 
analyzed separately for each subject. Maximal 
ST segment depression and ischemic burden 
(product of the change in ST segment ampli-
tude and the duration of the recording) were 
determined for each lead and as a composite 
(Mills et al. 2007).
Ambulatory blood pressure was measured 
automatically (model 90217 ultralite ambu-
latory blood pressure monitor; Spacelabs 
Healthcare Ltd.) every 15 min during the 2-hr 
walk and then every 30 min during the day 
and every hour overnight (i.e., 2200 hours to 
0700 hours).
Symptom questionnaire. Subjects com-
pleted a symptom questionnaire at the begin-
ning of the study day, after the 2-hr walk, and 
at the end of the 24-hr visit. They were asked 
to report physical symptoms (e.g., headaches, 
dizziness, nausea), their perception of the pol-
lution, their perceived workload, and the tol-
erability of the mask after the prescribed walk 
using a visual analog scale.
Data analysis and statistical methods. 
In our previous study of healthy volunteers, 
we demonstrated a difference (mean ± SD) 
in systolic blood pressure of 7 ± 5 mmHg 
after a 2-hr walk when a face mask was used 
(Langrish et al. 2009). Based on the assump-
tion that the effect size in the present study 
would be considerably smaller because of the 
use of cardiac medications, we powered the 
study to detect a 2-mmHg difference in sys-
tolic blood pressure, giving a sample size of 
101 at 80% power and two-sided p < 0.05.
Blood pressure and ECG end points were 
analyzed by investigators unaware of treatment 
allocation. All data are expressed as medians 
(interquartile ranges) or means ± SD unless 
otherwise stated. Treatment × period (order in 
which the mask intervention was used) interac-
tions were assessed as described previously (Hills 
and Armitage 1979), before data were com-
pared using paired Student’s t-tests or Wilcoxon 
matched pairs signed rank test as appropriate. 
Occurrence of arrhythmias, reported symp-
toms, and ST segment event frequency, were 
compared using the chi-squared analysis. All 
data were analyzed using GraphPad Prism (ver-
sion 4 for Macintosh; GraphPad Software, San 
Diego, CA, USA). Statistical significance was 
taken as a two-sided p < 0.05.
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Results
Subjects and face mask intervention. Ninety-
eight patients (87% male; mean age, 62 years) 
completed the study protocol (Table 1). Four 
of those originally enrolled did not complete 
the protocol because of withdrawn consent, 
cataract extraction, or withdrawal by investi-
gators because of smoking or failure to walk 
the prescribed route. All subjects tolerated the 
mask intervention well, scoring the comfort 
of the mask as 0.64 ± 1.06 on a 0–10 scale (0 
represents completely comfortable, and 10, 
intolerable). The mask intervention reduced 
self-reported general symptoms (Figure 1) and 
patients’ perceived effort of work, as well their 
perception of the level of ambient air pollution 
(2.46 ± 1.67 vs. 2.73 ± 1.64 on the 0–10 visual 
analog scale; p = 0.03). There were no signifi-
cant treatment × period interactions for any 
outcome measure.
Air quality and pollutants. Personal  levels 
of ambient air pollutants were similar on both 
study days (Table 2), although we predict 
from previous studies of filter efficacy (97% 
reduction in particle number) that the PM 
exposure in the presence of the mask would 
be reduced from 89 μg/m3 and 43,900 par-
ticles/cm3 to approximately 2 μg/m3 and 
1,200 particles/cm3 (Langrish et al. 2009). 
Temperature (17.3°C vs. 16.8°C) and ambi-
ent relative humidity (30% vs. 35%) were 
similar on both visits. Airborne PM was pre-
dominantly (> 99% by particle number) in 
the fine and ultrafine fractions (Figure 2) and 
contained a large amount of organic carbon 
and high concentrations of polycyclic aro-
matic hydrocarbons, nitrates, hopanes, and 
steranes, suggesting that much of the PM 
was combustion derived and related to traffic 
sources [see Supplemental Material, Table S1 
(http://dx.doi.org/10.1289/ehp.1103898)]. 
These collected particles were highly oxi-
dizing and generated large amounts of free 
radicals as detected by EPR, exceeding the 
signal seen with both the standard reference 
NIST urban dust material at an equivalent 
concentration and the intense free-radical– 
generating  oxidant pyrogallol (Figure 2).
Effect of the face mask on cardio vascular 
health. Over the 24-hr period, the maximal 
ST segment depression recorded was lower 
[median (interquartile range), –142 μV 
(–179 to –110) vs. –156 μV (–202 to –123); 
p = 0.046] when the face mask was used. 
However, measures of myocardial ischemic 
burden were similar during the 2-hr walk and 
over the entire 24-hr period between visits 
(Table 3).
During the 2-hr prescribed city center 
walks, subjects walked a comparable distance 
(6.37 ± 1.44 km vs. 6.40 ± 1.51 km), at a 
similar average speed (4.25 ± 0.96 km/hr vs. 
4.27 ± 1.01 km/hr), and expended the same 
amount of energy [2.32 ± 0.52 metabolic 
equivalent tasks (METs) vs. 2.33 ± 0.55 
METs] between visits when the face mask was 
or was not used. Despite this similar workload, 
mean ambulatory arterial blood pressure 
was significantly lower (93 ± 10 mmHg 
Table 1. Baseline characteristics of subjects 
(n = 98) completing the study.
Characteristic Measure
Age (years) 62 ± 7
Male 85
Height (cm) 169 ± 6
Weight (kg) 75 ± 10
BMI (kg/m2) 26 ± 3
Risk factors
Hypertension 79
Diabetes mellitus 45
Stroke 15
Peripheral vascular disease 5
Previous myocardial infarction 68
Previous PCI 60
Previous CABG 38
LV ejection fraction (%; n = 31) 62 ± 9
Angina status
CCS class I 67
CCS class II 31
Seattle angina score (maximum, 500) 387 ± 34
Clinical biochemistry
Random glucose (mmol/L) 5.5 ± 1.8
Triglycerides (mmol/L) 1.5 ± 0.7
Cholesterol (mmol/L) 3.9 ± 0.9
HDL cholesterol (mmol/L) 1.2 ± 0.3
LDL cholesterol (mmol/L) 2.0 ± 0.8
Medication use
Aspirin 92
Clopidogrel 17
Warfarin 1
ACE inhibitor or ARB 54
Beta blocker 73
Calcium channel blocker 42
Statin (fibrate, or ezetimibe) 83
Nitrate 45
Other antianginal 5
Diabetic medication 42
Traditional Chinese medicine 19
Abbreviations: ACE, angiotensin converting enzyme; ARB, 
angiotensin II receptor blocker; BMI, body mass index; 
CABG, coronary artery bypass graft; CCS, Canadian 
Cardiovascular Society; HDL, high density lipoprotein; 
LDL, low density lipoprotein; LV, left ventricle; PCI, percu-
taneous coronary intervention. Data are mean ± SD, or n.
Figure 1. Self-reported symptoms of well-being in the presence or absence of the face mask.
*p < 0.05.
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Table 2. Personal ambient pollution exposures and background pollution levels on days defined according 
to mask use.
Parameter Mask No mask
Personal PM2.5 exposure (μg/m3)
Measured 61 (20–88) 89 (25–170)
Estimated ~ 2 (0.6–2.6) 89 (25–170)
Personal particle count (× 104 particles/cm3)
Measured 4.19 ± 1.29 4.39 ± 1.45
Estimated ~ 0.12 ± 0.04 4.39 ± 1.45
Personal temperature (°C) 17.3 ± 5.2 16.8 ± 5.8
Personal relative humidity (%) 30.4 ± 14.0 34.8 ± 18.2
Personal peaks > 1 ppm (number)
NO2 None None
SO2 None None
CO 5 (2–7.5) 4 (2–8)
Background exposure 
PM10 (μg/m3) 92 (70–117) 103 (83–180)
SO2 (ppb) 38 (29–53) 54 (32–77)
NO2 (ppb) 36 (29–42) 36 (32–47)
Abbreviations: CO, carbon monoxide; NO2, nitrogen dioxide; SO2, sulfur dioxide. Data are mean ± SD or median (inter-
quartile range). Personal monitoring data were collected using portable monitoring equipment during the 2-hr walk. 
Background data were collected from permanent monitoring stations for the whole 24-hr period. Estimated PM exposure 
is calculated based on filter efficacy studies where 97% of fresh diesel exhaust PM were removed (Langrish et al. 2009).
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vs. 96 ± 10 mmHg) when the face mask 
was used, although heart rate was similar 
(Table 3). During the 2-hr walk, heart rate 
variability [high-frequency (HF) power, high-
frequency normalized power (HFn), HF:low-
frequency (LF) ratio, and root mean square 
successive differences (RMSSD)] was higher 
when wearing the face mask (Table 3). There 
were no significant differences in overall 
24-hr ambulatory blood pressure or heart 
rate variability. There were no significant 
differences in the incidence of arrhythmias 
between the two visits (Table 4).
Discussion
PM air pollution is a major public health 
concern and is associated with increases in 
cardio vascular morbidity and mortality. In this 
study, we demonstrated that reducing personal 
exposure to urban airborne PM by means of a 
simple face mask is associated with a reduction 
in self-reported symptoms and improvements 
in objective measures of myocardial ischemia, 
blood pressure, and heart rate variability in 
patients with coronary heart disease. Reducing 
personal exposure to PM air pollution has the 
potential to reduce the incidence of cardio-
vascular events in patients with coronary heart 
disease living and working in industrialized or 
urban environments.
Using a robust PROBE design, we con-
ducted a randomized controlled trial to assess 
the impact of reducing personal air pollu-
tion exposure in patients with coronary heart 
disease in a polluted urban environment. 
Through the use of portable monitoring 
devices and sample collection, we completed 
a detailed characterization of air pollutant 
exposure that demonstrated the remarkably 
complex and toxic composition and extremely 
high prooxidative potential of ambient air 
PM in Beijing. We combined individualized 
pollution monitoring with a comprehensive 
cardiovascular assessment that incorporated 
hemodynamic and electrophysiological mon-
itoring in conjunction with GPS tracking. 
Despite reducing exposure only for a 48-hr 
period in patients chronically exposed to a 
polluted urban environment, we observed 
evidence of consistent beneficial effects on a 
range of biomarkers of cardiovascular health 
after the introduction of this simple but 
highly efficient face mask intervention.
Myocardial ischemia. In a cohort of 20 
men with stable asymptomatic coronary 
disease, we previously demonstrated greater 
exercise-induced maximum ST segment 
depression during exposure to diesel exhaust 
(Mills et al. 2007). However, although acute 
air pollution exposure exacerbates myocardial 
ischemia, many persons around the world are 
chronically exposed to high levels of air pollu-
tion, and it is unknown whether interventions 
targeted at reducing exposure will decrease 
myocardial ischemia.
In the present study, we showed that 
decreasing personal exposure to ambient 
air pollution reduces maximal ST segment 
depression over a 24-hr period in patients 
with coronary heart disease. The significance 
of silent myocardial ischemia is still debated, 
but it has been associated with major car-
diac events in the general population (Fleg 
et al. 1990). Moreover, in patients with recent 
myocardial infarction or unstable angina, the 
occurrence of silent ischemia is a poor prog-
nostic factor and is associated with a signifi-
cant increase (relative risk ~ 3–4) in major 
cardiac events and death (Cohn et al. 2003). 
It seems plausible, therefore, that the mod-
est reduction in silent myocardial ischemia 
seen in this study might, if sustained, result in 
significant reductions in major cardiac events 
and cardiovascular mortality.
Blood pressure. Chronic exposure to air 
pollution is associated with increases in blood 
pressure in large epidemiological studies 
(Auchincloss et al. 2008). Similarly controlled 
exposure to concentrated ambient PM and 
ozone in healthy volunteers results in an acute 
increase in diastolic blood pressure (Urch et al. 
2005). Hypertension is a major risk factor for 
atherosclerosis, and acute increases in blood 
pressure may trigger plaque rupture leading 
to an acute cardiovascular event. Consistent 
with this, exercise-related increases in blood 
pressure are predictive of the incidence of myo-
cardial infarction (Mundal et al. 1996), stroke 
(Kurl et al. 2001), and cardiovascular mortality 
(Kikuya et al. 2000).
We recently reported that use of a face 
mask that decreased personal PM air pollu-
tion exposure reduced systolic blood pressure 
in healthy volunteers during a 2-hr walk by 
7 mmHg (Langrish et al. 2009). The more 
modest 3-mmHg difference in mean arterial 
blood pressure after a 2-hr walk observed in 
the present study may be explained at least in 
part by the lower workload during walking 
in this older population with heart disease 
(estimated energy expenditures of 2.32 METs 
vs. 3.61 METs in the previous study popu-
lation), coupled with the modifying effects 
of anti hypertensive medications (Barclay 
et al. 2009), which were used by most of the 
present study population. However, inter-
ventional trials of blood pressure reduction 
Figure 2. (A) Representative filter samples collected showing contribution by mass of the three size fractions averaged over 3 days. (B) Estimated contribution 
of each size fraction collected on filters by particle number. (C) Oxidative potential of the collected Beijing PM (1 mg/mL) using EPR to assess oxygen-centered 
free radical generation, compared with NIST diesel exhaust PM (10 μg/mL) and urban dust (1 mg/mL) and the prooxidant positive control (pyrogallol 100 μM) as 
described previously (Miller et al. 2009). Data are mean ± SD (n = 2–4).
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suggest that even modest changes in blood 
pressure would reduce the incidence of major 
cardiovascular events at the population level 
(Williams 2005).
Heart rate variability. Heart rate vari-
ability is a reflection of the autonomic control 
(a balance of the sympathetic and parasym-
pathetic nervous systems) of the heart and is 
a measure of the variation in the RR inter-
vals on a continuous electrocardiogram. A 
reduction in heart rate variability has been 
demonstrated in patients with a variety of 
pathophysiological conditions, including 
hypertension, heart failure, and diabetes melli-
tus (Task Force 1996). Indeed, reduced heart 
rate variability has been linked to increased 
cardiovascular mortality (Nolan et al. 1998), 
and a large number of studies link exposure 
to air pollutants with a reduction in heart rate 
variability (Brook et al. 2010).
In the present study, we have shown that 
reducing personal exposure to PM air pollu-
tion in patients with coronary heart disease 
is associated with an improvement in heart 
rate variability during exercise, based on gen-
eral measures of variability and variability in 
specific frequency bands. In this study, the 
changes demonstrated were predominantly 
in the HF-power band, which is associated 
with changes in parasympathetic tone, and 
an improvement may suggest an increased 
contribution of parasympathetic (vagal) tone 
to heart rate control. In our previous healthy 
volunteer study (Langrish et al. 2009), heart 
rate variability also increased after the face 
mask intervention, but changes were seen 
predominantly in the LF-power band, sug-
gesting effects on sympathetic nervous sys-
tem control. We suggest that this difference 
(HF-power vs. LF-power changes) may be 
related to the high use of beta-blocker ther-
apy (74% of patients) in the present study 
population, which is likely to blunt any 
effects of exposure on sympathetic tone. The 
clinical relevance of acute changes in heart 
rate variability is not clear, although it has 
been demonstrated that the higher the vari-
ability, the lower the cardiovascular mortality 
(Kikuya et al. 2000). We suggest that a sus-
tained improvement in heart rate variability 
has the potential to improve patients’ prog-
nosis and reduce the impact of air pollution 
on cardiovascular morbidity and mortality.
Symptoms. Patients perceived fewer self-
reported symptoms, a reduction in effort of 
work, and lower background pollution levels 
when they wore the face mask. Although we 
observed no change in the occurrence of self-
reported anginal symptoms, this is perhaps 
not surprising given that we recruited a highly 
selected popu lation with stable coronary disease, 
without significant clinical angina, and who 
were maintained on optimal medical therapy.
Limitations. We chose a PROBE study 
design because we wanted to determine the 
acceptability of wearing a face mask, as well as 
its potential beneficial effects on both symp-
toms and objective measures of cardiovascu-
lar health. We recognize that a double-blind 
approach incorporating a sham mask would 
reduce the potential for subjective bias and 
would therefore be considered more scientifi-
cally robust (Smith et al. 2007). In addition, 
we acknowledge that such an intervention 
may be more readily accepted in Chinese 
and Asian societies, where use of face masks 
is commonplace because of concerns over air-
borne diseases, pollution, and even fashion, 
and furthermore, that this may have affected 
patients’ reporting of symptom improvement. 
However, even a sham mask will filter air pol-
lutants to some degree (Langrish et al. 2009), 
Table 3. Ambulatory blood pressure, heart rate variability during the 2-hr city center walk and the 24-hr study period, and myocardial ischemia measured as 
ischemic burden, in each individual territory and as a composite according to face mask use.
Walk 24 hr
Parameter Mask No mask Mask No mask
Systolic blood pressure (mmHg) 126.9 ± 15.9 128.1 ± 16.5 121.2 ± 11.9 120.8 ± 12.4
Diastolic blood pressure (mmHg) 78.0 ± 9.3 79.5 ± 8.6 73.8 ± 7.2 74.0 ± 7.3
Mean arterial pressure (mmHg) 93.3 ± 9.7* 95.7 ± 10.0 89.8 ± 7.5 90.0 ± 7.9
Heart rate (bpm) 81.5 ± 8.7 81.5 ± 10.1 77.6 ± 11.3 76.7 ± 11.1
LF power (msec2) 133 (68–97) 136 (52–227) 81 (40–172) 93 (46–208)
HF power (msec2) 54 (27–108)* 40 (20–69) 27 (11–77) 31 (11–68)
LFn (msec) 58.4 (45.6–69.1)* 62.9 (51.1–75.5) 67.2 (55.5–78.0) 71.1 (59.4–81.1)
HFn (msec) 23.5 (18.0–32.4)* 20.5 (13.5–27.9) 21.4 (15.0–31.6) 20.9 (12.7–30.1)
HF:LF ratio 0.418 (0.258–0.712) 0.328 (0.207–0.573) 0.301 (0.190–0.554) 0.306 (0.161–0.492)
pNN50 (%) 1.2 (0.2–2.8) 0.7 (0.0–2.3) 0.5 (0.0–3.1) 0.6 (0.0–2.6)
RMSSD (msec) 16.7 (13.2–22.5)* 14.8 (10.9–19.6) 15.5 (11.0–22.6) 14.4 (10.3–20.3)
SDNN (msec) 59.8 (46.4–79.1) 60.1 (41.0–79.3) 45.6 (30.8–70.4) 48.2 (30.0–66.3)
Ischemic burden (mV-sec)
Inferior (II) territory –66 (–118 to –26) –52 (–149 to –21) –641 (–767 to –504) –615 (–820 to –473)
Anterior (V2) territory –66 (–142 to –16) –50 (–124 to –13) –597 (–859 to –435) –632 (–905 to –489)
Lateral (V5) territory –37 (–104 to –8) –43 (–85 to –18) –604 (–811 to –429) –586 (–790 to –412)
Sum (II + V2 + V5) –189 (–382 to –90) –188 (–340 to –112) –1,930 (–2,306 to –1,541) –1,934 (–2,391 to –1,575)
Abbreviations: LFn, low frequency–normalized; pNN50, percentage of successive RR intervals that differ by > 50 msec; SDNN, standard deviation of RR intervals. Data are mean ± SD, 
or median (interquartile range). LFn and HFn are normalized units to account for variation in the total power and very low-frequency components. LF and SDNN reflect mainly sympa-
thetic nervous stimulation; HF, pNN50, and RMSSD reflect parasympathetic tone.
*p < 0.05 from Wilcoxon matched pairs signed rank test or Student’s paired t-tests as appropriate, mask versus no mask.
Table 4. Cardiac arrhythmias during 24-hr electrocardiographic monitoring periods among 98 coronary 
heart disease patients according to face mask use.
No. patients
Median no. of events per patient 
(interquartile range)
Arrhythmia Mask No mask Mask No mask
Dropped beat 2 2 1 (1–1) 1 (1–1)
VT 1 2 2 (2–2) 1 (1–1)
Salvo 1 2 4 (4–4) 2 (1–3)
Bigeminy 15 18 4 (1–33) 6 (2–36)
Triplet 1 0 11 (11–11) 0 (0–0)
Couplet 9 4 2 (1–5) 2 (1–10)
Bradycardia 20 19 52 (3–275) 89 (9–347)
SVT 2 5 1 (1–1) 1 (1–1)
Trigeminy 3 4 12 (6–134) 10 (6–230)
Premature aberrant 79 77 17 (3–122) 22 (3–181)
Isolated aberrant 52 54 3 (1–16) 5 (1–25)
Premature normal 81 84 12 (3–56) 12 (3–42)
Abbreviations: SVT, supraventricular tachycardia; VT, ventricular tachycardia. Bradycardia defined as heart rate < 50 bpm.
p > 0.05 for all using chi-squared (number of patients) and Mann–Whitney U-tests (number of events).
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and true blinding is difficult to achieve given 
that large differences in mask efficiency would 
be readily apparent to trial participants, and 
differences in mask design would be obvious 
to investigators. It would also be anticipated 
that the greater effort of breathing through a 
mask during exercise would lead to an increase 
in blood pressure rather than the reverse.
We have assessed an acute intervention, 
and it remains to be seen whether wearing a 
face mask for more prolonged periods would 
have sustained benefits that could affect clinical 
outcomes.
Conclusions
In this randomized controlled crossover 
intervention trial, we observed that reducing 
personal exposure to PM air pollution was 
associated with small but consistent improve-
ments in objective measures of myocardial 
ischemia, exercise-related increases in blood 
pressure, and heart rate variability in patients 
with coronary heart disease. Although efforts 
to reduce emissions are critical to reducing 
exposures to the population as a whole, use 
of a face mask may be an effective individual-
level intervention for high-risk populations. 
The use of a face mask has the potential to 
reduce the incidence of acute cardiovascular 
events, as well as improving patients’ general 
well-being, particularly in developing coun-
tries where pollutant exposures are high and 
resources to reduce emissions are limited.
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